Hematologic Cancer

HEMATOLOGIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

The Twitter Effect on How Oncologists Conduct and Share Research

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials

It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma

Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile.
Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
Examining Progress and Future Directions in Follicular Lymphoma Treatment

Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.

HEMATOLOGIC CANCER NEWS

DLBCL is a rare, B-cell non-Hodgkin’s lymphoma that affects older adults.

No Benefit From Early Rituximab Intensification During DLBCL Treatment

August 11, 2020

Long-Term Zanubrutinib Treatment Effective for Majority of Patients With Waldenström Macroglobulinemia

August 10, 2020

New cancer-specific designs are needed to balance out heart and cancer outcomes in the chronic disease setting of CLL.

Risk-Stratified Therapy Reduces Late Morbidity, Mortality in Pediatric Acute Lymphoblastic Leukemia

August 10, 2020

A doctor explains a medication to an older patient.

Venetoclax With Chemotherapy: Promising for Elderly Patients With AML?

August 7, 2020

Multiple Myeloma

COVID-19 Case Fatality Rate 29 Percent in Multiple Myeloma Patients

August 6, 2020

Next post in Hematologic Cancers

A doctor explains a medication to an older patient.

Venetoclax With Chemotherapy: Promising for Elderly Patients With AML?